G1 Therapeutics, Inc.

NASDAQ:GTHX

7.16 (USD) • At close September 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 16.54614.47614.87312.342.39212.94610.2523.57610.5736.9025.7964.8586.60414.21816.54626.5992.1400000103.2100000000000
Cost of Revenue 0.7331.0791.2563.0761.4041.4590.9921.1110.9760.6690.3740.5910.8080.24300000021.9821.49451.60515.87318.385015.07514.05413.66711.0849.1415.6956.4543.871
Gross Profit 15.81313.39713.6179.22440.98811.4879.25822.4659.5976.2335.4224.2675.79613.97516.54626.5992.14000-21.982-1.49451.605-15.873-18.3850-15.075-14.054-13.667-11.084-9.141-5.695-6.454-3.871
Gross Profit Ratio 0.9560.9250.9160.750.9670.8870.9030.9530.9080.9030.9350.8780.8780.983111000000.500000000000
Reseach & Development Expenses 5.7387.3187.388.81112.0415.4816.58719.58120.84326.30519.7921.14318.75216.5416.37417.93218.53120.43424.49222.94123.48918.0819.07715.87318.38517.34715.07514.05413.66711.0849.1415.6956.4543.871
General & Administrative Expenses 000000000024.26824.2680024.2618.41214.43111.38712.06111.0839.0947.8017.0094.9493.2683.3782.2061.8751.7121.2941.2610.9180.9752.075
Selling & Marketing Expenses 0000000000-1.0500000000000000000000000
SG&A 13.6115.12715.16616.78117.43221.75323.55824.43225.71626.70923.21824.26825.23622.9724.2618.41214.43111.38712.06111.0839.0947.8017.0094.9493.2683.3782.2061.8751.7121.2941.2610.9180.9752.075
Other Expenses 0.5670.5260.5483.0760.5690.5240.2370.048-0.127-0.155-0.138-0.076-0.092-0.04-0.054-0.291-0.2140.7981.1121.661.8931.9291.9940.9040.7850.3150.30.3280.1850.0740.0640.0560.050.012
Operating Expenses 19.34822.44522.54628.66829.47237.23340.14544.01346.55953.01443.00845.41143.98839.5140.63436.34432.96231.82136.55334.02432.58325.88126.08620.82221.65320.72517.28115.92915.37912.37810.4026.6137.4295.946
Operating Income -3.535-9.048-8.929-16.36811.516-25.746-30.887-21.548-36.962-46.781-37.586-41.144-38.192-25.535-24.088-9.745-30.822-31.821-36.553-34.024-32.583-25.881-26.086-20.822-21.653-20.725-17.281-15.929-15.379-12.378-10.402-6.613-7.429-5.946
Operating Income Ratio -0.214-0.625-0.6-1.3310.272-1.989-3.013-0.914-3.496-6.778-6.485-8.469-5.783-1.796-1.456-0.366-14.40300000-0.25300000000000
Total Other Income Expenses Net -1.934-1.171-1.047-0.931-1.498-1.849-2.281-2.505-2.484-2.411-2.188-1.003-1.01-0.769-0.78-0.998-0.3880.7981.1111.661.8931.9291.9950.9040.7850.3150.30.3280.1850.0330.0010.0560.05-0.008
Income Before Tax -5.469-10.219-9.976-17.29910.018-27.595-33.168-24.053-39.446-49.192-39.774-42.147-39.202-26.304-24.868-10.743-31.21-31.023-35.441-32.364-30.69-23.952-24.092-19.918-20.868-20.41-16.981-15.601-15.194-12.345-10.401-6.557-7.379-5.954
Income Before Tax Ratio -0.331-0.706-0.671-1.4060.236-2.132-3.236-1.02-3.731-7.127-6.862-8.676-5.936-1.85-1.503-0.404-14.58400000-0.23300000000000
Income Tax Expense 00.0770.9020.9051.3084.9380.4811.2192.4842.4110.2460.3210.220.1380.4790.9310.0510-0.14100-0.064-0.060000000.0410.063000.02
Net Income -5.469-10.219-10.878-18.2048.71-32.533-33.649-25.272-41.93-51.603-40.02-42.468-39.422-26.442-25.347-11.674-31.21-31.023-35.441-32.364-30.69-23.952-24.092-19.918-20.868-20.41-16.981-15.601-15.194-12.345-10.401-6.557-7.379-5.954
Net Income Ratio -0.331-0.706-0.731-1.480.205-2.513-3.283-1.072-3.966-7.477-6.905-8.742-5.969-1.86-1.532-0.439-14.58400000-0.23300000000000
EPS -0.1-0.2-0.21-0.350.17-0.63-0.73-0.59-0.98-1.21-0.94-1-0.94-0.65-0.67-0.31-0.83-0.82-0.94-0.86-0.82-0.64-0.65-0.59-0.64-0.7-0.6-0.55-1.07-0.46-0.51-0.32-0.36-0.29
EPS Diluted -0.1-0.2-0.21-0.350.14-0.63-0.73-0.59-0.98-1.21-0.94-1-0.94-0.65-0.67-0.31-0.83-0.82-0.94-0.86-0.82-0.64-0.65-0.59-0.64-0.7-0.58-0.55-1.07-0.46-0.51-0.32-0.36-0.29
EBITDA -2.622-8.928-8.805-15.05712.858-24.374-30.035-21.15-36.9-46.812-37.472-41.096-38.157-25.436-23.968-9.841-30.787-31.662-36.411-33.938-32.518-25.817-26.026-20.774-21.618-20.693-17.251-15.902-15.359-12.366-10.379-6.595-7.415-5.934
EBITDA Ratio -0.206-0.617-0.592-1.3310.303-1.893-2.93-0.897-3.49-6.782-6.507-8.459-5.778-1.789-1.457-0.37-14.38600000-0.25300000000000